A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
Titel:
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
Auteur:
Borner, M.M. Bernhard, J. Dietrich, D. Popescu, R. Wernli, M. Saletti, P. Rauch, D. Herrmann, R. Koeberle, D. Honegger, H. Brauchli, P. Lanz, D. Roth, A.D.